The MTTP gene helps your body package fats in the liver and intestines so they can travel through the bloodstream. If it does not work properly, fat and fat-soluble vitamins may not be absorbed well, which can lead to poor growth, diarrhea, very low cholesterol, and over time problems with the nerves, eyes, or liver. Some variants in the MTTP gene may also affect blood fat levels without causing the full condition.
What is a gene?
A gene is a section of DNA that gives your cells instructions for making molecules or guiding processes in the body. Some genes carry the code for proteins, the parts of cells that do much of the work. Other genes mainly control when certain processes happen, where they happen, and how strongly they run. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. If you want to look at this topic more closely, you can find more in the LearnHub.
Overview
MTTPGene function
What if the gene works
The MTTP gene helps your liver and intestines package fats with proteins so they can travel in blood. This supports absorption of dietary fat and the transport of cholesterol and fat soluble vitamins.
Risk
What if the gene does not work
Reduced function of the MTTP gene can cause abetalipoproteinemia, with poor fat absorption, very low blood fats, growth problems, and vitamin deficiency; milder or more severe variants can influence when symptoms appear and how strongly eyes and nerves are affected.
Treatment
What does that mean for your treatment
Pathogenic variants in the MTTP gene usually shift treatment toward a very low long chain fat diet, use of medium chain triglycerides, and lifelong high dose vitamins E, A, D, and K. This approach helps improve nutrient absorption and can reduce eye, nerve, and liver complications, with vitamin doses adjusted over time to blood levels and symptoms.
Conditions associated with MTTP
Gene function
What if the gene works
Your body needs a steady way to package and move fats after you eat and between meals. The MTTP gene supports this work mainly in the small intestine and liver. Its protein helps load fats onto transport particles so they can travel through the bloodstream. This is part of how your body absorbs dietary fat after a meal.
Inside gut and liver cells, the MTTP gene moves triglycerides, cholesterol, and similar fats onto fat-carrying particles. This loading step gives those particles the cargo they need before leaving the cell.
This gene helps cells assemble chylomicrons and VLDL, two kinds of fat-carrying particles used by the body. These particles need a stable outer structure so they can be released into the bloodstream.
In the small intestine, the MTTP gene supports the release of chylomicrons after a meal. This lets absorbed fat and fat-soluble vitamins, such as vitamins A, D, E, and K, move from the gut into the bloodstream.
In the liver, the MTTP gene helps package triglycerides into VLDL for transport through the blood. This gives the liver a normal route to send fats to muscles, fat tissue, and other organs.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help explain normal differences among people, such as appearance, metabolism, or the way the body responds to environmental influences. Many do not have any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant affects how a gene works more substantially and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the MTTP gene can reduce or block the protein's ability to load fats onto lipoproteins, the particles that carry fat and cholesterol through cells and blood. This change in how MTTP gene variants affect fat transport can range from mild to severe. Some variants leave partial activity, while more disruptive variants can nearly shut the process down. When both copies are strongly affected, this loss of function is linked to abetalipoproteinemia, which often appears earlier and with more pronounced features.
How variants are linked to conditions
Pathogenic variants in the MTTP gene cause abetalipoproteinemia when both copies of the gene are affected. MTTP gene variants linked to abetalipoproteinemia can lead to very low cholesterol, trouble absorbing fat and vitamins, poor growth, diarrhea, nerve symptoms, and eye changes over time. Some common MTTP variants have also been associated with differences in blood lipid levels or fatty liver risk, but these findings reflect risk trends rather than a diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely found across the general population. Most do not directly affect health and instead reflect normal human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In other situations, though, one well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For MTTP-related abetalipoproteinemia, risk is mainly determined by the genes you inherit, usually when both copies of the MTTP gene carry a disease-causing change. Lifestyle does not meaningfully change the chance of having this inherited condition, but early diagnosis and treatment can lower the risk of complications such as nerve, eye, and vitamin problems.
Inheritance of MTTP variants
MTTP-related abetalipoproteinemia follows an autosomal recessive inheritance pattern, which means a person usually inherits one MTTP variant from each parent. Parents who each carry one variant are often unaffected carriers, and with each pregnancy there is a 25% chance of having an affected child, a 50% chance of having a child who is also a carrier, and a 25% chance of having a child with no familial MTTP variant. In families looking into how MTTP variants are inherited, this pattern means sons and daughters are affected equally.
What does my MTTP result mean for my family?
For families with an MTTP-related condition, close relatives may also carry the same gene change, even if they feel well. Brothers and sisters may be affected or may be healthy carriers, and parents are usually carriers. Other relatives on both sides of the family may also carry the change, so the result can matter beyond one person.
Genetic information
Genetic testing
How you find out about variants
MTTP genetic testing uses a blood, saliva, or cheek swab sample to look for variants in the MTTP gene. A lab reads the DNA sequence and compares it with the usual pattern. Results may show a pathogenic variant, a benign variant, or a variant of uncertain significance, which means its health effect is not yet clear.
When should I consider getting a genetic test?
Genetic testing for the MTTP gene may be worth considering if someone has low cholesterol along with trouble absorbing fat, oily stools, poor growth, or low levels of vitamins A, D, E, and K, especially from infancy. It can also help if there is a family history of this inherited condition or a known MTTP variant in the family.
A genetic result is only one part of your health story
Genetic results can offer useful insight, but how much they reveal depends on the condition and the specific type of variant. Over time, many factors, including lifestyle, environment, age, and medical history, also shape how the body functions. For some conditions, especially those influenced by many genes, genetic information offers context instead of certainty and is best interpreted alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, these results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can influence how your body responds to certain medicines. Small inherited differences can change how a drug is absorbed, moved through the body, broken down, or how strongly it acts on its target. This helps explain why the same treatment may work well for one person, work less well for another, or cause more side effects in someone else. These differences are common and are just one part of medication response, along with factors like age, liver and kidney function, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medication. It studies the relationship between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes affect either how strongly a drug works or how the body processes it. This information can support treatment choices that are more informed and more individualized. If you want to read more about this topic, you can learn more in the LearnHub.
Drugs influenced by the MTTP gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so questions about medicines, side effects, or your overall health are best discussed with your doctor.
History
Across cultures and time periods, inherited patterns were noted in families with very low blood fats and trouble absorbing dietary fat. In the late 20th century, researchers connected these clinical patterns to microsomal triglyceride transfer protein, and the MTTP gene was identified as the genetic cause in many people with abetalipoproteinemia. This helped explain a long-standing medical puzzle that had first been recognized through symptoms rather than DNA testing. From these first observations, research expanded steadily, linking MTTP variants to inherited lipid conditions and improving genetic diagnosis. The way this gene was viewed has shifted over time, moving from a rare clinical clue to an established part of modern lipid genetics.